Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] Sam Rubinstein et al. Mike Thompson, MD, PhD, FASCO COVID-19 and Cancer Consortium (CCC19) Registry Blood Cancer Discovery ow.ly/wC8F50IgpjR #COVID19 nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] Dimpy Shah MD, PhD Pankil Mike Thompson, MD, PhD, FASCO Transplant ID onlinelibrary.wiley.com/doi/10.1111/ti… #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc

So wonderful to see this out! Comprehensive immune profiling to flu vaccine responses in MPN patients - more data from this collaboration to come! #mpnsm

👉👉👉Quick pic with some of the fabulous group at MD Education after MPN talks session Day #1 ! 🙌Jeanne M Palmer Rami komrokji Stephen Oh Lucia Masarova, MD Ruben A. Mesa, MD Prithviraj Bose Naveen Pemmaraju, MD Guillermo Montalban-Bravo Shilpa Paul Pankit Vachhani Abdulraheem Yacoub Maximilian Stahl Sanam Loghavi, MD صنم لغوی 🔬🧬 || #MPNSM

The quality of the company matches the weather #MPNSM Naveen Pemmaraju, MD Stephen Oh Ruben A. Mesa, MD

👏🏻 👏🏻 Largest contemporary analysis to date focussed on outcomes from MMRD allo-HCT in Myelofibrosis from our working party! The EBMT #MPNsm

Dr Ruben Mesa Ruben A. Mesa, MD giving an outstanding talk on JAK inhibitors for myelofibrosis #MFsm joined by panelist Dr Nikolai Podoltsev Yale Cancer Center who also summarized all prognostic scores with excellent moderatation by Dr Prithviraj Bose at MD Education #MDSsm & #MPNsm meeting

📣 #ESHMPN2024 READ THE FINAL PROGRAMME!
The Conference starts on April 26th in Mandelieu 🇫🇷
Last days to register: proceed now ➡️ bit.ly/3PALAGS
10th Translational Research Conference on #MPN
Chairs: J.J. Kiladjian, Ross Levine, Jyoti Nangalia
#ESHCONFERENCES #MPN sm

When the #ManOfTheDay #Co -Chair of MPN-MDS US focus meeting MD Education hits the stage !! The one and only Prithviraj Bose can publish and decipher this figure 😊 #MPNsm awesome session, #novel agents made easy #Myelofibrosis

MPN legend Pr Tiziano Barbui discussing the very early stages of #MPNsm at #IHEM24

Our Dr. Lucia Masarova discusses recent advancements in myeloproliferative neoplasms, including results from TRANSFORM-1 and MANIFEST-2 studies and other emerging therapeutic approaches.

Watch here: brnw.ch/21wIV3g Targeted Oncology Lucia Masarova, MD #MPNSM #EndCancer

CONGRESS #EBMT24 | Alzbeta Zavrelova Charles University presents long term outcomes of allo-HCT in primary and secondary MF from a single cohort. Median OS was 114.2 months (OS in 1 year was 81%) and the median PFS was not reached. 31% of pts relapsed. #MPN #MPN sm #medicalcongress

CONGRESS #EBMT24 | Lorenzo Lazzari, San Raffaele Scientific Institute discusses treosulfan based conditioning for allo-HCT from a single center analysis. OS, PFS and GRFS were 80.4%, 80.7% and 60.5% at 2-years. RI was 9.8% at 2-years. #MPN #MPN sm #medicalcongress

👉👉👉Great to spend some time with Amer Zeidan MBBS,MHS ‏عامر زيدان at MD Education meeting ! #OslerTie #OslerFriday Amy DeZern Rakhi Naik, MD MHS Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center Ryan J Tedford MD Tatiana Prowell, MD Mike Fradley, MD Dr. Patrick Hwu The Osler Medical Residency | #MPNSM #MDSsm

CONGRESS #EBMT24 | Emma Kempshall University Hospital of Wales discusses current practices when transplanting patients with MF. FB-ATG remains the most common conditioning regimen used across the UK, however, dosing schedules vary. #MPN #MPN sm #medicalcongress

CONGRESS #EBMT24 | Moniek de Witte UMC Utrecht presents TCRalphabeta/CD19-depletion allo-HCT plus post transplant RUX in MF. CI of grade 2-4 and 3-4 aGVHD at D100 was 17% and 10%. The 2-year NRM was 19%. #MPN #MPN sm #medicalcongress

👉👉👉Superb clinic team discussions and new ideas 💡 & patient-centered brainstorming for new approaches after MPN clinic with awesome #TeamPemm this week !! Shout to and make sure to follow Dr Danielle Hammond, MD Dr Hannah Goulart Dr Ani Lankford !!! #MPNSM #VEXAS #BPDCN #leusm

👉👉👉Wonderful to be speaking about exciting new directions in MPNs at MPN-MDS MD Education meeting in San Diego this weekend with Ruben A. Mesa, MD & colleagues ! #MPNSM Rami komrokji Amer Zeidan MBBS,MHS ‏عامر زيدان Lucia Masarova, MD Naval Daver, M.D. Sanam Loghavi, MD صنم لغوی 🔬🧬 Fadi Haddad, MD Prithviraj Bose

CONGRESS #EBMT24 | Mariam Amer University Hospital Southampton 💙 discusses long term survival and rates of GVHD in pts with MF after allo-HCT in a single cohort. Median OS was not reached, median GFRS was 8.9 years and transplant related mortality was 17%. #MPN #MPN sm #medicalcongress

The wait is OVER!
My MPN Voice App has landed!
If you registered an interest (UK only), keep an eye on your inbox for onboarding details!

Not registered and from the UK? Request access here -linktr.ee/Mpnvoice

The App will be open to non-UK patients shortly...
#mpnsm